<DOC>
	<DOCNO>NCT00979316</DOCNO>
	<brief_summary>The purpose study determine effect BMS-708163 QTc interval ( QT interval correct heart rate ) .</brief_summary>
	<brief_title>Effect Electrocardiographic QT Interval Corrected Heart Rate ( QTc ) Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Body Mass Index ( BMI ) 18 32 kg/mÂ² , inclusive . Women childbearing potential ( ie , postmenopausal surgically sterile ) men , age 18 55 Healthy subject History cardiac arrhythmia palpitation associate presyncope syncope , history unexplained syncope Sexually active fertile men use effective birth control ( double barrier ) partner WOCBP Women pregnant breastfeed History allergy intolerance moxifloxacin member quinolone class antimicrobial agent History hypokalemia , history family history prolong QT interval , family history sudden cardiac death young age Any clinically significant ECG abnormality History seizure disorder History drown survival</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>